The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Open accessAbstract
The altered metabolism of tumors has been considered a target for anticancer therapy. However, the relationship between distinct tumor-initiating lesions and anomalies of tumor metabolism in vivo has not been addressed. We report that MYC-induced mouse liver tumors significantly increase both glucose and glutamine catabolism, whereas MET-induced liver tumors use glucose to produce glutamine. Increased glutamine catabolism in MYC-induced liver tumors is associated with decreased levels of glutamine synthetase (Glul) and the switch from Gls2 to Gls1 glutaminase. In contrast to liver tumors, MYC-induced lung tumors display increased expression of both Glul and Gls1 and accumulate glutamine. We also show that inhibition of Gls1 kills cells that overexpress MYC and catabolize glutamine. Our results suggest that the metabolic profiles of tumors are likely to depend on both the genotype and tissue of origin and have implications regarding the design of therapies targeting tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, inhibiting glutamine entry into the TCA cycle can blunt tumor progression in a MYC-driven cancer model of liver cancer (Xiang et al., 2015; Yuneva et al., 2012) and a MYC-inducible Burkitt lymphoma model (Le et al., 2012; Xiang et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“MYC has been found to increase mRNA and protein levels of glutamine transporters as well as expression of the enzyme glutaminase, which catalyzes the first step in glutaminolysis (Gao et al., 2009; Wise et al., 2008; Yuneva et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“Second, although different oncogenes reprogram metabolism in different ways, the tissue in which the oncogene is expressed affects the execution of metabolic reprogramming.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“Transgenic MYC induces metabolic changes in both liver tumors and lung tumors but activates glutamine catabolism in lung tumors and glutamine synthesis in liver tumors.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [179]
In the citing paper
“For example, liver tumors with aberrant overexpression of MYC display enhanced glutamine oxidation and sensitivity to therapies that target glutamine catabolism relative to liver tumors driven by overexpression of MET (196).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [196]
In the citing paper
“furthermore, a similar accumulation of glucose-derived glutamine within the tumor tissue was observed in a mouse model of c-Met-driven liver cancer (Yuneva et al., 2012).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yuneva et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,456
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 638
Famine versus feast: understanding the metabolism of tumors in vivo
Mayers, J. R., & Heiden, M. G. V. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.004 · Cited by 190
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
Chen, L., & Cui, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922830 · Cited by 184
Han, J., Zhang, L., Guo, H., Wysham, W. Z., Roque, D. R., Willson, A. K., Sheng, X., Zhou, C., & Bae-Jump, V. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.036 · Cited by 182
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
Liu, M., Jiang, L., & Guan, X. (2014) · Protein & Cell · doi:10.1007/s13238-014-0065-9 · Cited by 183
Cell cycle regulators in cancer cell metabolism
Leal-Esteban, L. C., & Fajas, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165715 · Cited by 192
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
Impact of MYC in regulation of tumor cell metabolism
Wahlström, T., & Arsenian‐Henriksson, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.004 · Cited by 176
Mitochondrial Oxidative Stress and “Mito-Inflammation”: Actors in the Diseases
Patergnani, S., Bouhamida, E., Leo, S., Pinton, P., & Rimessi, A. (2021) · Biomedicines · doi:10.3390/biomedicines9020216 · Cited by 178
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Corbet, C., & Féron, O. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.002 · Cited by 174
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Morita, M., Sato, T., Nomura, M., Sakamoto, Y., Inoue, Y., Tanaka, R., Ito, S., Kurosawa, K., Yamaguchi, K., Sugiura, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.004 · Cited by 170
Metabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2016) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 176
Rapid Analysis of Glycolytic and Oxidative Substrate Flux of Cancer Cells in a Microplate
Winer, L., & Wu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109916 · Cited by 173
Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
Matés, J. M., Paola, F. J. D., Campos-Sandoval, J. A., Mazurek, S., & Márquez, J. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.012 · Cited by 169
Self-citationAdapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Kreuzaler, P. A., Panina, Y., Segal, J., & Yuneva, M. O. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.021 · Cited by 170
Self-citationOncogenic regulation of tumor metabolic reprogramming
Tarrado‐Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 165
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
Matteis, S. D., Ragusa, A., Marisi, G., Domenico, S. D., Gardini, A. C., Bonafè, M., & Giudetti, A. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7512159 · Cited by 160
Nwosu, Z. C., Battello, N., Rothley, M., Piorońska, W., Sitek, B., Ebert, M. P. A., Hofmann, U., Sleeman, J. P., Wölfl, S., Meyer, C., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0872-6 · Cited by 156
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Tumour metabolism and its unique properties in prostate adenocarcinoma
Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 162
β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Senni, N., Savall, M., Granados, D. C., Alves‐Guerra, M., Sartor, C., Lagoutte, I., Gougèlet, A., Terris, B., Gilgenkrantz, H., Perret, C., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315448 · Cited by 160
Liao, M., Liao, W., Xu, N., Li, B., Liu, F., Zhang, S., Wang, Y., Wang, S., Zhu, Y., Chen, D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.035 · Cited by 152
Simón, J., Núñez-García, M., Fernández-Tussy, P., Barbier-Torres, L., Fernández-Ramos, D., Gómez-Santos, B., Buqué, X., Lopitz-Otsoa, F., Goikoetxea-Usandizaga, N., Serrano-Maciá, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.013 · Cited by 141
Redox control of glutamine utilization in cancer
Alberghina, L., & Gaglio, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.513 · Cited by 150
Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Wolpaw, A. J., & Dang, C. V. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 151
O-GlcNAcylation: The Sweet Side of the Cancer
de Queiroz, R. M., Carvalho, Ã., & Dias, W. B. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00132 · Cited by 151
Kwon, M.-C., & Berns, A. J. M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.010 · Cited by 150
FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells
Yeo, H., Lyssiotis, C. A., Zhang, Y., Ying, H., Asara, J. M., Cantley, L. C., & Paik, J.-H. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.186 · Cited by 148
Identifying strategies to target the metabolic flexibility of tumours
Méndez‐Lucas, A., Lin, W., Driscoll, P. C., Legrave, N. M., Novellasdemunt, L., Xie, C., Charles, M. D., Wilson, Z., Jones, N. P., Rayport, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0195-8 · Cited by 148
Self-citationKRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00848 · Cited by 151
Ortmayr, K., Dubuis, S., & Zampieri, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09695-9 · Cited by 142
de la Cova, C., Senoo‐Matsuda, N., Ziosi, M., Wu, D. C., Bellosta, P., Quinzii, C. M., & Johnston, L. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.012 · Cited by 140
Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
Nieminen, A. I., Eskelinen, V., Haikala, H. M., Tervonen, T. A., Yan, Y., Partanen, J. I., & Klefström, J. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208530110 · Cited by 142
Metabolic features of cancer stem cells: the emerging role of lipid metabolism
Mancini, R., Noto, A., Pisanu, M. E., Vitis, C. D., Maugeri‐Saccà, M., & Ciliberto, G. (2018) · Oncogene · doi:10.1038/s41388-018-0141-3 · Cited by 140
Tumour microenvironment factors shaping the cancer metabolism landscape
Anastasiou, D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.412 · Cited by 138
Hopefully devoted to Q: targeting glutamine addiction in cancer
Still, E. R., & Yuneva, M. O. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.113 · Cited by 142
Self-citationShort overview on metabolomics approach to study pathophysiology of oxidative stress in cancer
Andrišić, L., Dudzik, D., Barbas, C., Milković, L., Grune, T., & Žarković, N. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.009 · Cited by 137
Metabolic Reprogramming in Brain Tumors
Venneti, S., & Thompson, C. B. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044329 · Cited by 139
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Jin, N., Bi, A., Lan, X., Xu, J., Wang, X., Liu, Y., Wang, T., Tang, S., Zeng, H., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10427-2 · Cited by 129
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
Nie, M., Yao, K., Zhu, X., Chen, N., Xiao, N., Wang, Y., Peng, B., Yao, L., Li, P., Zhang, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26685-y · Cited by 130
Wang, B., Hsu, S., Wang, X., Kutay, H., Bid, H. K., Yu, J., Ganju, R. K., Jacob, S. T., Yuneva, M. O., & Ghoshal, K. (2013) · Hepatology · doi:10.1002/hep.26712 · Cited by 128
Self-citationStalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Butler, E. B., Zhao, Y., Muñoz‐Pinedo, C., Lu, J., & Tan, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3009 · Cited by 126
Metabolic vulnerability of cisplatin‐resistant cancers
Obrist, F., Michels, J., Durand, S., Chery, A., Pol, J. G., Lévesque, S., Joseph, A., Astesana, V., Pietrocola, F., Wu, G. S., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798597 · Cited by 122
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124
Deng, S.-J., Chen, H., Zeng, Z., Deng, S., Zhu, S., Zeng, Y., He, C., Liu, M., Huang, K., Zhong, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0419 · Cited by 120
Self-citationNon-invasive metabolic imaging of brain tumours in the era of precision medicine
Kim, M. M., Parolia, A., Dunphy, M. P., & Venneti, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.108 · Cited by 121
Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take
Altea‐Manzano, P., Cuadros, A. M., Broadfield, L. A., & Fendt, S. (2020) · EMBO Reports · doi:10.15252/embr.202050635 · Cited by 123
Pardee, T. S., Lee, K. C., Luddy, J. S., Maturo, C., Rodriguez, R., Isom, S. P., Miller, L. D., Stadelman, K. M., Levitan, D. A., Hurd, D. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1019 · Cited by 121
Dong, G., Chen, W., Wang, X., Yang, X., Xu, T., Wang, P., Zhang, W., Rao, Y., Miao, C., & Sheng, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00467 · Cited by 117
Metabostemness: A New Cancer Hallmark
Menéndez, J. A., & Alarcón, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00262 · Cited by 116
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis
Diolaiti, D., McFerrin, L. G., Carroll, P. A., & Eisenman, R. N. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.016 · Cited by 115
Hominoid-specific enzyme GLUD2 promotes growth of IDH1 R132H glioma
Chen, R., Nishimura, M. C., Kharbanda, S., Peale, F., Deng, Y., Daemen, A., Forrest, W. F., Kwong, M., Hedehus, M., Hatzivassiliou, G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409653111 · Cited by 112
The Pleiotropic Effects of Glutamine Metabolism in Cancer
Bott, A. J., Maimouni, S., & Zong, W. (2019) · Cancers · doi:10.3390/cancers11060770 · Cited by 111
Yu, D., Shi, X., Meng, G., Chen, J., Chen, Y., Jiang, Y., Wei, J., & Ding, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3196 · Cited by 108
Okazaki, A., Gameiro, P. A., Christodoulou, D. C., Laviolette, L. A., Schneider, M., Chaves, F. L., Stemmer-Rachamimov, A. O., Yazinski, S. A., Lee, R. E., Jr., Stephanopoulos, G. N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87800 · Cited by 110
Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
Li, B., & Simon, M. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3629 · Cited by 108
Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM)
Bruntz, R. C., Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.776054 · Cited by 107
Self-citationSola‐Penna, M., Paixão, L. P., Branco, J. R., Ochioni, A. C., Albanese, J. M., Mundim, D. M., Baptista‐de‐Souza, D., Figueiredo, C. P., Coelho, W. S., Marcondes, M. C., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0640-1 · Cited by 103
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
Todisco, S., Convertini, P., Iacobazzi, V., & Infantino, V. (2019) · Cancers · doi:10.3390/cancers12010068 · Cited by 105
Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
Kim, J. H., Lee, K. J., Seo, Y., Kwon, J.-H., Yoon, J. P., Kang, J. Y., Lee, H. J., Park, S. J., Hong, S. P., Cheon, J. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18762-4 · Cited by 104
Self-citationEpigenetics and Metabolism in Health and Disease
Tzika, E., Dreker, T., & Imhof, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00361 · Cited by 106
Lowman, X. H., Hanse, E. A., Yang, Y., Gabra, M. B. I., Tran, T. Q., Li, H., & Kong, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.037 · Cited by 102
Glutamine Addiction In Gliomas
Márquez, J., Alonso, F. J., Matés, J. M., Segura, J. A., Martín‐Rufián, M., & Campos-Sandoval, J. A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2212-1 · Cited by 106
Self-citationProteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
Bernhardt, S., Bayerlová, M., Vetter, M., Wachter, A., Mitra, D., Hanf, V., Lantzsch, T., Uleer, C., Peschel, S., John, J., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0905-7 · Cited by 104
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 105
Harding, J. J., Telli, M. L., Münster, P. N., Voss, M. H., Infante, J. R., DeMichele, A. M., Dunphy, M. P., Le, M. H., Molineaux, C., Orford, K. W., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1204 · Cited by 98
Glutaminase isoenzymes in the metabolic therapy of cancer
Matés, J. M., Campos-Sandoval, J. A., & Márquez, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.007 · Cited by 99
Self-citationSirniö, P., Väyrynen, J. P., Klintrup, K., Mäkelä, J. T., Karhu, T., Herzig, K., Minkkinen, I., Mäkinen, M. J., Karttunen, T. J., & Tuomisto, A. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0357-6 · Cited by 101
Glutamine Metabolism in Brain Tumors
Natarajan, S. K., & Venneti, S. (2019) · Cancers · doi:10.3390/cancers11111628 · Cited by 99
Regulation of rDNA transcription in response to growth factors, nutrients and energy
Kusnadi, E. P., Hannan, K. M., Hicks, R. J., Hannan, R. D., Pearson, R. B., & Kang, J. (2014) · Gene · doi:10.1016/j.gene.2014.11.010 · Cited by 105
Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition
Han, S., Zhu, L., Zhu, Y., Meng, Y. G., Li, J., Song, P., Yousafzai, N. A., Feng, L., Chen, M., Wang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.60028 · Cited by 95
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Nan, D., Yao, W., Huang, L., Liu, R., Chen, X., Xia, W., Sheng, H., Zhang, H., Liang, X., & Lü, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02018-6 · Cited by 98
Self-citationDefining a metabolic landscape of tumours: genome meets metabolism
Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 95
Self-citationEmerging roles of long non-coding RNAs in tumor metabolism
Sun, H., Huang, Z., Sheng, W., & Xu, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0648-7 · Cited by 93
Mitochondrial and metabolic alterations in cancer cells
Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 97
Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
Lane, A. N., Higashi, R. M., & Fan, T. W.-M. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.007 · Cited by 91
Self-citationGlutaminases regulate glutathione and oxidative stress in cancer
Matés, J. M., Campos-Sandoval, J. A., de los Santos-Jiménez, J., & Márquez, J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02838-8 · Cited by 91
Self-citation“In vitro” 3D models of tumor-immune system interaction
Hirt, C., Papadimitropoulos, A., Mele, V., Muraro, M. G., Mengus, C., Iezzi, G., Terracciano, L., Martín, I., & Spagnoli, G. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.003 · Cited by 93
Cerebral gluconeogenesis and diseases
Yip, J., Geng, X., Shen, J., & Ding, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00521 · Cited by 89
Splicing regulator SLU7 is essential for maintaining liver homeostasis
Elizalde, M., Urtasun, R., Azkona, M., Latasa, M. U., Goñi, S., García‐Irigoyen, O., Uriarte, I., Segura, V., Collantes, M., Scala, M. D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74382 · Cited by 89
Méndez‐Lucas, A., Li, X., Hu, J., Che, L., Song, X., Jia, J., Wang, J., Xie, C., Driscoll, P. C., Tschaharganeh, D. F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0498 · Cited by 90
Self-citationFerreira, A. P. S., Cassago, A., Gonçalves, K. D. A., Dias, M. M., Adamóski, D., Ascenção, C. F. R., Honorato, R. V., de Oliveira, J. F., Ferreira, I. M., Fornezari, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501346 · Cited by 88
Martín‐Rufián, M., Nascimento-Gomes, R., Higuero, A., Crisma, A. R., Campos-Sandoval, J. A., Gómez-García, M. C., Cardona, C., Cheng, T., Lobo, C., Segura, J. A., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1105-2 · Cited by 88
Self-citationBlüml, S., Margol, A., Sposto, R., Kennedy, R. J., Robison, N. J., Vali, M., Hung, L. T., Muthugounder, S., Finlay, J. L., Erdreich‐Epstein, A., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov097 · Cited by 87
Norberg, E., Lako, A., Chen, P.-H., Stanley, I. A., Zhou, F., Ficarro, S. B., Chapuy, B., Chen, L., Rodig, S. J., Shin, D. H., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.116 · Cited by 87
Wu, D., Zhuo, L., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.003 · Cited by 88
Oliynyk, G., Ruiz-Pérez, M. V., Sainero‐Alcolado, L., Dzieran, J., Zirath, H., Gallart‐Ayala, H., Wheelock, C. E., Johansson, H. J., Nilsson, R., Lehtiö, J., et al. (2019) · iScience · doi:10.1016/j.isci.2019.10.020 · Cited by 92
Metabolic pathway analysis using stable isotopes in patients with cancer
Bartman, C., Faubert, B., Rabinowitz, J. D., & DeBerardinis, R. J. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00632-z · Cited by 93
Activated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 93
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 88
Glutamine Synthetase as a Therapeutic Target for Cancer Treatment
Kim, G. W., Lee, D. H., Jeon, Y. H., Yoo, J. H., Kim, S. Y., Lee, S. W., Cho, H. Y., & Kwon, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041701 · Cited by 86
Targeting GLS1 to cancer therapy through glutamine metabolism
Yu, W., Yang, X., Zhang, Q., Sun, L., Yuan, S., & Xin, Y. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02645-2 · Cited by 86
Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells
Bernfeld, E., & Foster, D. A. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.03.003 · Cited by 85
Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer.
Huang, F., Zhao, Y., Zhao, J., Wu, S., Jiang, Y., Ma, H., & Zhang, T. (2014) · PubMed Central · Cited by 85
Bogorad, R. L., Yin, H., Zeigerer, A., Nonaka, H., Ruda, V. M., Zerial, M., Anderson, D. G., & Koteliansky, V. (2014) · Nature Communications · doi:10.1038/ncomms4869 · Cited by 86
Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
Michalak, K. P., Maćkowska-Kędziora, A., Sobolewski, B., & Woźniak, P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/964321 · Cited by 85
Loss of RBF1 changes glutamine catabolismPreprint
Nicolay, B., Gameiro, P. A., Tschöp, K., Korenjak, M., Heilmann, A. M. F., Asara, J. M., Stephanopoulos, G. N., Iliopoulos, O., & Dyson, N. J. (2013) · Genes & Development · doi:10.1101/gad.206227.112 · Cited by 91
Nicolay, B., Danielian, P. S., Kottakis, F., Lapek, J. D., Sanidas, I., Miles, W. O., Dehnad, M., Tschöp, K., Gierut, J. J., Manning, A. L., et al. (2015) · Genes & Development · doi:10.1101/gad.264127.115 · Cited by 84
Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers, J. R., & Heiden, M. G. V. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0165 · Cited by 86
Targeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Strohecker, A. M., & White, E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0196 · Cited by 83
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
Tambay, V., Raymond, V., & Bilodeau, M. (2021) · Cancers · doi:10.3390/cancers13174484 · Cited by 91
Metadata
- Authors
- Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X., & Bishop, J. M.
- Affiliations
- University of California, San Francisco (US)
- University of Louisville (US)
- Johns Hopkins University (US)
- Universidad de Málaga (ES)
- Corresponding author
- Yuneva, Mariia O.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 15
- Issue
- 2
- Pages
- 157-170
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3282107
- OpenAlex
- W2036659083
- Cited by
- 639
- References
- 64
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 35 · 2023: 41 · 2022: 53 · 2021: 66 · 2020: 43 · 2019: 59 · 2018: 45 · 2017: 63 · 2016: 47 · 2015: 39 · 2014: 42 · 2013: 34 · 2012: 16
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R35CA044338, R01CA118434)
- National Institute of Neurological Disorders and Stroke (R21NS074151)
- National Center for Research Resources (P20RR018733)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, c-Myc, MET, glutamine catabolism, glutamine synthetase, glutaminase, GLS1, GLS2, liver tumors, lung cancer, genetic lesions, glutamine accumulation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Citric Acid Cycle, Glucokinase, Glucose, Glutamine, Humans, Immunohistochemistry, Isotope Labeling, Liver Neoplasms, Experimental, Lung Neoplasms, Immunoblotting, Blotting, Western, Proto-Oncogene Proteins c-myc, DNA Primers, Lactic Acid, Proto-Oncogene Proteins c-met, Nuclear Magnetic Resonance, Biomolecular, RNA Interference, Cell Line, Tumor, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
